These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 11012477)

  • 21. Rabeprazole, amoxycillin and low- or high-dose clarithromycin for cure of Helicobacter pylori infection.
    Kihira K; Satoh K; Saifuku K; Kawakami S; Fukazawa K; Ishino Y; Kimura K; Sugano K
    Aliment Pharmacol Ther; 2000 Aug; 14(8):1083-7. PubMed ID: 10930904
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
    Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A
    Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supplementing vitamins C and E to standard triple therapy for the eradication of Helicobacter pylori.
    Sezikli M; Çetinkaya ZA; Güzelbulut F; Yeşil A; Coşgun S; Kurdaş OÖ
    J Clin Pharm Ther; 2012 Jun; 37(3):282-5. PubMed ID: 21740452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H; Nagahara A; Sato K; Ohkura R; Murai T; Shimizu H; Watanabe S; Sato N
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Sep; 34(6):604-17. PubMed ID: 21745241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of Helicobacter pylori infection.
    Reed PI; Johnston BJ
    Biomed Pharmacother; 1997; 51(1):13-21. PubMed ID: 9084725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: treatment of Helicobacter pylori infection with ranitidine bismuth citrate- or proton pump inhibitor-based triple therapies.
    Van Oijen AH; Verbeek AL; Jansen JB; De Boer WA
    Aliment Pharmacol Ther; 2000 Aug; 14(8):991-9. PubMed ID: 10930892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
    Puig I; Baylina M; Sánchez-Delgado J; López-Gongora S; Suarez D; García-Iglesias P; Muñoz N; Gisbert JP; Dacoll C; Cohen H; Calvet X
    J Antimicrob Chemother; 2016 Oct; 71(10):2740-53. PubMed ID: 27342548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
    Rakici H; Akdoğan RA; Bedir R; Copur A; Yilmaz A
    J Dig Dis; 2014 Sep; 15(9):508-13. PubMed ID: 24980811
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Superiority of Vonoprazan-based First-line Triple Therapy with Clarithromycin: A Prospective Multi-center Cohort Study on Helicobacter pylori Eradication.
    Sue S; Kuwashima H; Iwata Y; Oka H; Arima I; Fukuchi T; Sanga K; Inokuchi Y; Ishii Y; Kanno M; Terada M; Amano H; Naito M; Iwase S; Okazaki H; Komatsu K; Kokawa A; Kawana I; Morimoto M; Saito T; Kunishi Y; Ikeda A; Takahashi D; Miwa H; Sasaki T; Tamura T; Kondo M; Shibata W; Maeda S
    Intern Med; 2017; 56(11):1277-1285. PubMed ID: 28566587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
    Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
    Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T; Shirai N; Takashima M; Xiao F; Hanai H; Sugimura H; Ohashi K; Ishizaki T; Kaneko E
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.
    Kim SY; Lee SW; Jung SW; Koo JS; Yim HJ; Park JJ; Chun HJ; Lee HS; Choi JH; Kim CD; Ryu HS
    Helicobacter; 2008 Aug; 13(4):282-7. PubMed ID: 18665938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.
    Gisbert JP; Calvet X
    Aliment Pharmacol Ther; 2011 Dec; 34(11-12):1255-68. PubMed ID: 22017749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA; Van Rensburg CJ; Moola S; Kotze D; Marks IN
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
    Chan FK; Sung JJ; Suen R; Wu JC; Ling TK; Chung SC
    Aliment Pharmacol Ther; 2000 Jan; 14(1):91-5. PubMed ID: 10632651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.